Keith Katkin - Director at Syndax Pharmaceuticals Inc

Insider Transactions and Holdings

Role: Director
Issuer symbol: SNDX on Nasdaq
Entity type: Individual
Source evidence: Open source filing history

There are no Buy or Sell transactions made by Keith Katkin since 01 Jun 2025

Holdings reported by Keith Katkin for Syndax Pharmaceuticals Inc

Form 4 holding Director

Syndax Pharmaceuticals Inc

Security class: Common Stock
Shares / value: 124,000
Estimated value: $2,605,240
Report date: 04 Feb 2026
Price: $21.01
Ownership: Direct

Transactions reported by Keith Katkin for Syndax Pharmaceuticals Inc

Sym	Class	Transaction	%	Reported value	Reported price	Shares	Shares after	Date	Ownership

^* indicates a reported price that failed the local validity check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .